Orchestra BioMed Holdings (OBIO) Net Cash Flow (QoQ) (2021 - 2026)
Orchestra BioMed Holdings (OBIO) Net Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.64% |
| Dec 31, 2025 | -131.47% |
| Sep 30, 2025 | 5,701.25% |
| Jun 30, 2025 | 110.25% |
| Mar 31, 2025 | -17.02% |
| Dec 31, 2024 | -276.74% |
| Sep 30, 2024 | 386.38% |
| Jun 30, 2024 | 105.38% |
| Mar 31, 2024 | -163.02% |
| Dec 31, 2023 | 330.16% |
| Sep 30, 2023 | 216.75% |
| Jun 30, 2023 | -109.92% |
| Mar 31, 2023 | 98.59% |
| Dec 31, 2022 | -673.81% |
| Sep 30, 2022 | -112.85% |
| Jun 30, 2022 | 300.36% |
| Mar 31, 2022 | 67,355.07% |
| Dec 31, 2021 | 77.47% |
| Sep 30, 2021 | -227.03% |
| Jun 30, 2021 | 48.75% |